Searched for
PIRAMAL LIFESCIENCES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Exploring the Growth Potential of the Indian Pharmaceutical SectorThe Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...
- Bulk and block deals worth over Rs 8,400 crore this week. Piramal Enterprises, Airtel top chartsInvestors Shah Rakesh and Satpal Khattar sold shares worth Rs 697 crore and Rs 510 crore, respectively in Eric Lifesciences and IIFL Financ...
- Piramal Group may sell 11% Vodafone stake this yearPiramal Healthcare today said it plans to offload its 11 per cent stake in telecom major Vodafone India and is well on track.
- Switch from Piramal Lifesciences to some other pharma stocks for long term: Deepak MohoniDeepak Mohoni, Director, trendwatchindia.com in a chat with ET Now talks about Piramal Lifesciences and Suven Lifesciences.
- Milestone payment keeps the trigger on Piramal Lifesciences: Rajesh JainRajesh Jain, Director, Research & Sales, Mview: Marvadi Shares & Finance in a chat with ET Now talks about Piramal Lifesciences.
- Sun Pharma can give a 25-30% move: Devang VisariaDevang Visaria, chief strategist, devangvisaria.com, in a chat with ET Now talks about Piramal Lifesciences and Sun Pharma.
- Piramal is a desirable stock: Deepak Mohoni, director, trendwatchindia.comDeepak Mohoni, director, trendwatchindia.com, in a chat with ET Now talks about pharma stocks.
- Sell Bajaj Hindustan and park equity in Piramal LifeSciences: Sanjeev AgarwalBajaj Hindustan is a sell below 200 while Piramal LifeSciences is a defensive stock one can park equity in.
- Piramal to foray into PhytopharmaPiramal Healthcare Limited is planning to foray into phytopharma through launch of herbal products in the next financial year.
- Piramal Life lines up Rs 200 cr for new drug researchPiramal Lifesciences, the drug research company of the Piramal Group, will invest Rs 200 crore in the next two years for developing new med...
- Piramal to invest Rs 200 cr to develop new medicinesPiramal Lifesciences, the drug research company of the Piramal group, will invest Rs 200 crore in the next two years for developing new med...
- Piramal Lifesciences hits upper circuitShares of Piramal Lifesciences hit the upper circuit limit Wednesday following the company’s announcement that it has received regulatory a...
- Piramal to hire up to 400 people this yearDrug firm Piramal Healthcare said it will hire 300-400 people this year across the country, taking its total employee base to 7,400.
- Sanofi Aventis-Piramal deal falls through over valuationFrench pharmaceutical giant Sanofi Aventis’ proposed deal to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through...
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
- Drug cos to launch anti-Aids medicinePrices of popular anti-Aids medicine Tenofovir could soon fall as several Indian drug companies plan to launch their low-cost versions in t...
- Piramal Life mulls stake sale to fund R&DPiramal Lifesciences (PLSL) is exploring the option of outlicensing some of its lead molecules or equity stake dilution to fund the advance...
Load More
